-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Recursion Pharmaceuticals, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2020 to Q2 2024.
- Recursion Pharmaceuticals, Inc. Amortization of Intangible Assets for the quarter ending June 30, 2024 was $3.9M, a 144% increase year-over-year.
- Recursion Pharmaceuticals, Inc. Amortization of Intangible Assets for the twelve months ending June 30, 2024 was $14M, a 610% increase year-over-year.
- Recursion Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2023 was $8.5M, a 2143% increase from 2022.
- Recursion Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2022 was $379K, a 24.7% increase from 2021.
- Recursion Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2021 was $304K, a 141% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)